Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
218 participants
OBSERVATIONAL
2019-09-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Psychological Development of Children of Parents With and Without Affective Disorders
NCT00001170
Study of Children at Risk for Disruptive Behavior Disorders
NCT00001233
Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders
NCT01778504
Child and Adolescent Psychiatric Personality Structure
NCT05162287
Characterizing Psychological Consequences of Childhood Trauma
NCT00209105
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Disruptive Mood Dysregulation Disorder (DMDD) is characterized by chronic and severe irritability and anger in children. DMDD understood as severe or clinical irritability can be regarded as laying above a certain threshold on a irritability continuum. Due to DMDD being a relatively new and debated diagnosis there is an urgent need to gain better understanding of the underlying mechanisms of severe irritability in children.
This study will explore emotion and behavior symptoms, neuropsychological functions (including social perception), perceived parental stress and attachment styles, and cortisol levels of children and their mothers, in children referred to outpatient psychiatric service including children with severe irritability. Parents of children 6 to 12 years will be informed and asked to participate.
The work on severe irritability will be divided into six main areas:
1. Severe irritability in a Norwegian clinical population: prevalence, comorbidity and associated difficulties
2. Social and emotional understanding in severe irritability in children
3. Executive function in severe irritability in children
4. Stress response in severe irritability in children
5. Parental stress and attachment style in parents of severe irritability in children
6. DMDD: An affective or conduct disorder? Comparing anxiety and depressive symptoms
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children referred to outpatient clinic
Diagnostic interview (Schedule for Affective Disorders and Schizophrenia (K-SADS) cf. Diagnostic and Statistical Manual of Mental Disorders (DSM-5)) with parents. Diagnostic groups/cohorts (e.g., DMDD, ADHD, Oppositional Defiant Disorder) will be based on the diagnoses given cf. K-SADS.
No interventions assigned to this group
Typical developing children and their parent(s)
Norm values on hair cortisol data will be obtained from typical developing children and their parent(s) by the same procedure as described under Outcome measure(s), 21. Stress Response by Cortisol levels.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intelligence quotient (IQ) within normal range
* Child and parents: Good enough understanding of Norwegian language to give valid answers in interview and tests.
* Clarified care situation
Exclusion Criteria
* Child and parents: Not good enough understanding of Norwegian language to give valid answers in interview and tests
* Unclarified care situation
6 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Linkoeping University
OTHER_GOV
Lovisenberg Diakonale Hospital
OTHER
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pål Zeiner
Head of Child Psychiatric Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pål Zeiner, PhD
Role: STUDY_DIRECTOR
Head of Child Psychiatric Research at Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Child and Adolescent Psychiatry, Oslo University Hospital
Oslo, , Norway
Nic Waals Institute, Lovisenberg Hospital
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Regional Committees for Medical and Health Research Ethics Approval
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017/135
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.